• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The global prevalence of atrial fibrillation (AF) has increased substantially over the past
three decades and is currently approximately 60 million cases. Incident AF and its clinical …

Background: Atrial fibrillation (AF) and atrial flutter (AFL) are associated with both diabetes
mellitus and its related comorbidities, including hypertension, obesity, and heart failure (HF) …

Background Cardiac arrhythmias are associated with poorer outcomes in patients with heart
failure (HF), diabetes mellitus (DM), and chronic kidney disease (CKD). Previous studies …

The population suffering from coronary heart disease (CHD) complicated by atrial fibrillation
(AF) is rising rapidly. A strong correlation between the two diseases has been reported, and …

Background Type 2 diabetes is closely related to an increased risk of atrial fibrillation (AF)
and atrial flutter (AFL). Whether sodium-glucose cotransporter 2 (SGLT2) inhibitors can …

Atrial fibrillation (AF) has heterogeneous patterns of presentation concerning symptoms,
duration of episodes, AF burden, and the tendency to progress towards the terminal step of …

The incidence of both atrial fibrillation (AF) and coronary artery disease (CAD) increases
with advancing age. They share common risk factors and very often coexist. Evidence points …

Obesity epidemic reached the dimensions of a real global health crisis with more than one
billion people worldwide living with obesity. Multiple obesity-related mechanisms cause …